Partner
Ningling Wang, managing partner of the firm's Shanghai office, has over 20 years of experience in various intellectual property fields. Her practice involves patent prosecution, opinions, due diligence, client counseling, licensing, and patent litigation in the areas of chemicals, chemical engineering, pharmaceuticals, medical devices, semiconductor materials, 3D printing, and nanotechnology.
Ningling has extensive experience working with multinational and Chinese companies, providing legal advice on IP portfolio management, due diligence, licensing, litigation, and trade secret protection and enforcement. She has been involved in various cases before the U.S. International Trade Commission (ITC) and U.S. district courts. She also has represented companies with IP enforcement in China, including judicial and customs enforcement actions.
Ningling frequently speaks at conferences and seminars in China and internationally on patent-related topics. She has taught graduate courses on U.S. IP law at Renmin University of China Law School and at Shanghai Jiao Tong University KoGuan Law School, where the curriculum included a mock patent trial. Ningling also served as a program professor of law at China Science and Technology University. Currently, she is an adjunct professor with Dalian University of Science and Technology, School of Law.
Ningling has been recognized by Intellectual Asset Management as a Global Leader, a leader in patent transactions in China, as well as for patent prosecution. She was named a top IP strategist in the IAM Strategy 300 list, which identifies individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. World Intellectual Property Review named Ningling as a WIPR Leader for patents in China.
NOTE: No aspect of these rankings has been approved by the Supreme Court of New Jersey. Further information on methodologies is available via these links.
Certain Light Emitting Diode Chips, Laser Diode Chips and Products Containing Same
Defended five Chinese LED companies in ITC litigations.
337-TA-674, ITC, Judge Luckern
Certain Sulfentrazone, Sulfentrazone Compositions, and Processes for Making Sulfentrazone
Defended two Chinese agro-chemical companies, defeating a petition for a temporary exclusion order and prevailing at trial, holding the patent invalid and not infringed.
337-TA-914, ITC, Judge Lord
Certain Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
337-TA-1238, ITC, Judge McNamara
Prosecuting patents for startup Hutchison Medipharma
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
Two-Way Radio Equipment and Systems, Related Software, and Components Thereof
337-TA-1053, ITC, Judge McNamara
Certain Short-Wavelength Light Emitting Diodes, Laser Diodes and Products Containing Same
337-TA-640, ITC, Judge Luckern
Event
2024 LES Thailand Annual Conference: Cutting-Edge Strategies for Global IP Licensing 2024 LES Thailand Annual Conference: Cutting-Edge Strategies for Global IP Licensing
February 16, 2024
Bangkok
Event
Power-Nation Institute Training Program Power-Nation Institute Training Program
October 27, 2023
Nanging
Event
Intellectual Property Internationalization Talent Training Course Intellectual Property Internationalization Talent Training Course
July 28-30, 2023
Beijing
Event
12th Pesticide Intellectual Property and Technology Innovation Conference 12th Pesticide Intellectual Property and Technology Innovation Conference
July 19-21, 2023
Qingdao
Event
21st Advanced Summit on Life Sciences Patents 21st Advanced Summit on Life Sciences Patents
May 18-19, 2023
New York
"Ningling Wang captains the [Shanghai] team immaculately, thanks to her profound knowledge of IP matters. Familiar with the intricacies of US IP law, Wang effortlessly handles Chinese invalidation proceedings, akin to inter partes reviews."
Intellectual Asset Management Patent 1000
“A superb strategist, Ningling Wang takes the lead on patent related issues across diverse industries. Familiar with the ins and outs of U.S. IP law, Wang effortlessly handles Chinese invalidation proceedings akin to inter partes reviews.”
Intellectual Asset Management Patent 1000
“With Ningling Wang at the helm, [Shanghai] navigates the patent landscape adroitly for clients in numerous industry sectors. Well versed in U.S. law, the consummate IP strategist shines brightest in the contentious IP field – she is highly recommended for inter partes review proceedings in the United States.”
Intellectual Asset Management Patent 1000
“Managing partner of the firm's China office Wang Ningling enjoys a strong track record in patent prosecution and litigation, particularly in the pharmaceutical and technology sectors. Peers observe: ‘Her name is well known; she's very active in the IP space.’”
Chambers Asia-Pacific
“Managing partner of the firm's Shanghai office Wang Ningling is particularly well versed in assisting on domestic clients' contentious and non-contentious patent mandates in the USA. Peers note: ‘She focuses on outbound work and really helps them to connect with counsel in the US.’"
Chambers Global
“Ningling Wang is managing partner of the firm's Shanghai office and has a wealth of experience providing counsel to Chinese and multinational clients on contentious and non-contentious patent mandates in the US. Clients reserve particular praise for her ‘very quick responses and very professional advice.’"
Chambers Global
“Ningling Wang offers expertise across a broad spectrum of patent issues in China and the USA, including litigation and portfolio management.”
Chambers Global
“Shanghai managing partner Ningling Wang is recommended by peers for her skills in advising domestic businesses on patent matters, both contentious and non-contentious, and especially as they relate to the USA. She frequently acts for clients in the chemical engineering, semiconductor material and nanotech industries.”
Chambers Global
“Managing partner of the Shanghai office, Ningling Wang is the primary point of contact…She is a dab hand at non-contentious matters, but also excels at enforcing IP rights and draws on extensive experience before the US district courts and International Trade Commission (ITC).”
Intellectual Asset Management Patent 1000
“The versatile all-rounder has a keen sense of long-term strategy.”
Intellectual Asset Management Patent 1000
“…is best known for her expertise in patent prosecution and litigation. She regularly advises businesses in the chemical, pharmaceutical and medical device sectors in China and the USA.”
Chambers Global
“Managing partner of the firm's Shanghai office Ningling Wang demonstrates considerable experience advising Chinese and international corporations on U.S. matters. She regularly acts for pharmaceutical and technology industry clients especially on patent prosecution and litigation issues.”
Chambers Global
“Ningling Wang heads up the Shanghai bureau with professionalism. Her diverse skill set guarantees her assistance through every stage of the patent lifecycle is invaluable.”
Intellectual Asset Management Patent 1000
“Teamwork is the name of Finnegan’s game; the personable Ningling Wang often works closely with Washington counterparts…to make great things happen. Her background in chemical and biomedical engineering works well with her experience in ITC proceedings and her client-centric approach. Wang garners high praise from clients as being ‘the best in the IP field in the Greater China region.’”
Intellectual Asset Management Patent 1000
“Ningling Wang captains the team immaculately thanks to her unfathomably deep knowledge of IP matters. Familiar with the intricacies of US IP law, Wang effortlessly handles Chinese invalidation proceedings akin to inter partes reviews.”
Intellectual Asset Management Patent 1000
"Ningling Wang captains the [Shanghai] team immaculately, thanks to her profound knowledge of IP matters. Familiar with the intricacies of US IP law, Wang effortlessly handles Chinese invalidation proceedings, akin to inter partes reviews."
Intellectual Asset Management Patent 1000
“A superb strategist, Ningling Wang takes the lead on patent related issues across diverse industries. Familiar with the ins and outs of U.S. IP law, Wang effortlessly handles Chinese invalidation proceedings akin to inter partes reviews.”
Intellectual Asset Management Patent 1000
“With Ningling Wang at the helm, [Shanghai] navigates the patent landscape adroitly for clients in numerous industry sectors. Well versed in U.S. law, the consummate IP strategist shines brightest in the contentious IP field – she is highly recommended for inter partes review proceedings in the United States.”
Intellectual Asset Management Patent 1000
“Managing partner of the firm's China office Wang Ningling enjoys a strong track record in patent prosecution and litigation, particularly in the pharmaceutical and technology sectors. Peers observe: ‘Her name is well known; she's very active in the IP space.’”
Chambers Asia-Pacific
“Managing partner of the firm's Shanghai office Wang Ningling is particularly well versed in assisting on domestic clients' contentious and non-contentious patent mandates in the USA. Peers note: ‘She focuses on outbound work and really helps them to connect with counsel in the US.’"
Chambers Global
“Ningling Wang is managing partner of the firm's Shanghai office and has a wealth of experience providing counsel to Chinese and multinational clients on contentious and non-contentious patent mandates in the US. Clients reserve particular praise for her ‘very quick responses and very professional advice.’"
Chambers Global
“Ningling Wang offers expertise across a broad spectrum of patent issues in China and the USA, including litigation and portfolio management.”
Chambers Global
“Shanghai managing partner Ningling Wang is recommended by peers for her skills in advising domestic businesses on patent matters, both contentious and non-contentious, and especially as they relate to the USA. She frequently acts for clients in the chemical engineering, semiconductor material and nanotech industries.”
Chambers Global
“Managing partner of the Shanghai office, Ningling Wang is the primary point of contact…She is a dab hand at non-contentious matters, but also excels at enforcing IP rights and draws on extensive experience before the US district courts and International Trade Commission (ITC).”
Intellectual Asset Management Patent 1000
“The versatile all-rounder has a keen sense of long-term strategy.”
Intellectual Asset Management Patent 1000
“…is best known for her expertise in patent prosecution and litigation. She regularly advises businesses in the chemical, pharmaceutical and medical device sectors in China and the USA.”
Chambers Global
“Managing partner of the firm's Shanghai office Ningling Wang demonstrates considerable experience advising Chinese and international corporations on U.S. matters. She regularly acts for pharmaceutical and technology industry clients especially on patent prosecution and litigation issues.”
Chambers Global
“Ningling Wang heads up the Shanghai bureau with professionalism. Her diverse skill set guarantees her assistance through every stage of the patent lifecycle is invaluable.”
Intellectual Asset Management Patent 1000
“Teamwork is the name of Finnegan’s game; the personable Ningling Wang often works closely with Washington counterparts…to make great things happen. Her background in chemical and biomedical engineering works well with her experience in ITC proceedings and her client-centric approach. Wang garners high praise from clients as being ‘the best in the IP field in the Greater China region.’”
Intellectual Asset Management Patent 1000
“Ningling Wang captains the team immaculately thanks to her unfathomably deep knowledge of IP matters. Familiar with the intricacies of US IP law, Wang effortlessly handles Chinese invalidation proceedings akin to inter partes reviews.”
Intellectual Asset Management Patent 1000
Award/Ranking
Seven Finnegan Partners Named IAM Global Leaders for 2024 Seven Finnegan Partners Named IAM Global Leaders for 2024
November 14, 2023
IAMPress Release
Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board
July 13, 2023
Managing Intellectual PropertyPress Release
Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked
June 30, 2023
Intellectual Asset ManagementAnnouncement
Finnegan’s Ningling Wang Joins LESI Board of Directors Finnegan’s Ningling Wang Joins LESI Board of Directors
May 9, 2023
Press Release
ITC Determines Healthgen’s Medium Grade Products Did Not Infringe Ventria’s Patent ITC Determines Healthgen’s Medium Grade Products Did Not Infringe Ventria’s Patent
September 16, 2022
Press Release
45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked 45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked
July 8, 2022
Intellectual Asset ManagementDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.